December 17, 2018 Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc
Laupheim, Germany and Milford, MA, USA, December 17, 2018 – Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today that the Company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA, USA.
The development and manufacturing site will be leveraged as a CDMO by Rentschler Biopharma. Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site.
The closing of the transaction is subject to the prior satisfaction or waiver of certain closing conditions. Financial terms of the transaction were not disclosed.
About Rentschler Biopharma SE
Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO), focused exclusively on clients' projects. Rentschler Biopharma offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. In order to offer optimal solutions across the entire value chain, the company has entered into a strategic alliance for formulation development with Leukocare AG and into a strategic partnership for fill & finish with Rentschler Fill Solutions GmbH. Rentschler Biopharma is a family-owned company employing more than 850 people.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication